Top Buy
| Security ▼ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Zoetis Inc. A | 27 | 1 | 4 | 0 | €169.38 | €196.17 | 15.814% |
| Vertex Pharmaceuticals Inc. | 60 | 2 | 11 | 0 | €433.65 | €440.93 | 1.678% |
| Veeva Systems A | 2 | 0 | 0 | 0 | €171.35 | - | - |
| Universal Health Services B | 14 | 6 | 3 | 1 | €204.00 | €185.12 | -9.255% |
| UnitedHealth Group Inc. | 41 | 1 | 9 | 0 | €530.60 | €547.91 | 3.263% |
| UCB S.A. | 1 | 0 | 0 | 0 | €152.65 | - | - |
| Thermo Fisher Scientific Inc. | 31 | 1 | 5 | 1 | €554.90 | €570.62 | 2.833% |
| Teva Pharmaceutical Industries Ltd ADR | 19 | 0 | 2 | 0 | €16.60 | €19.34 | 16.499% |
| Teleflex Inc. | 11 | 0 | 2 | 0 | €210.00 | €245.97 | 17.127% |
| Stryker Corp. | 31 | 0 | 7 | 0 | €309.00 | €340.29 | 10.127% |
| Steris Corp. | 1 | 0 | 0 | 0 | €214.00 | - | - |
| Smith & Nephew plc ADR | 3 | 0 | 1 | 0 | €26.80 | - | - |
| Smith & Nephew plc | 1 | 0 | 0 | 0 | €13.79 | - | - |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €121.30 | €130.00 | 7.172% |
| Sanofi S.A. ADR | 7 | 0 | 2 | 0 | €48.80 | €55.25 | 13.225% |
| Sanofi S.A. | 4 | 0 | 1 | 0 | €97.92 | €100.00 | 2.124% |
| Resmed Inc. | 21 | 0 | 2 | 0 | €202.00 | €215.00 | 6.436% |
| Regeneron Pharmaceuticals Inc. | 47 | 1 | 8 | 0 | €1,061.5 | €1,082.5 | 1.981% |
| Quest Diagnostics Inc. | 7 | 0 | 0 | 0 | €137.15 | €145.02 | 5.737% |
| Pfizer Inc. | 30 | 4 | 3 | 0 | €26.42 | €41.49 | 57.079% |
| Novo Nordisk A/S ADR | 22 | 1 | 2 | 0 | €124.50 | €146.33 | 17.533% |
| Novo Nordisk A/S | 5 | 0 | 0 | 0 | €185.00 | €195.00 | 5.405% |
| Novartis AG ADR | 3 | 0 | 0 | 0 | €103.50 | €112.40 | 8.597% |
| Merck KGaA | 5 | 2 | 2 | 1 | €168.45 | €172.00 | 2.107% |
| Merck & Co. Inc. | 33 | 1 | 4 | 0 | €104.00 | €125.72 | 20.883% |